Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Vaccination of chickens with a herpes virus of turkey vaccine with
carrying H9 gene of Avian Influenza Virus and F gene of Newcastle
Disease Virus diseases.

Proposed period of release:
01/09/2020 to 30/09/2021

Name of the Institute(s) or Company(ies)
Ceva Phylaxia Co Ltd, Szállás utca 5, Budapest, Hungary, 1107;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
R062 vaccine contains the live, cell-associated and genetically modified turkey herpes virus (strain FC-126 of HVT), expressing the Fusion protein (F) encoding gene of Newcastle disease virus (NDV) and the Haemagglutinin protein (HA) encoding gene of Low Pathogenic Avian Influenza Virus subtype H9 (LPAIV H9). The core construct of the R062 vaccine is the vaccine strain of Vectormune ND. This vaccine strain is a genetically modified form of the parent strain FC-126 of HVT containing one insert, the F protein of Newcastle Disease Virus. This GMO was further modified by inserting the artificially synthesized LPAIV H9 consensus HA gene between the SORF3 and the US2 genes of the HVT genome.

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
HVTMardivirusMeleagrid herpes virus 1-FC 126 strain-

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known